With syphilis rates rising across the country, the Centers for Disease Control (CDC) has awarded a $1.589 million grant to The Ohio State University faculty members Dr. William Miller, chair of the College of Public Health’s Division of Epidemiology, and Dr. Abigail Norris Turner, associate professor in the Division of Infectious Diseases in the College of Medicine, to help examine the reasons for the increase.
[Photo: Dr. Abigail Norris Turner (left) and Dr. William Miller (right)]
Dr. JaNelle Ricks, assistant professor of health behavior and health promotion in the College of Public Health, will help in community engagement and in developing approaches to recruit a diverse cohort of men to participate in the study. Other Ohio State researchers involved with the project include Dr. Jose Bazan, (Division of Infectious Diseases) and Dr. Joe Tien (Department of Mathematics).
The goal of the research is to identify behaviors and other characteristics which may increase syphilis risk, specifically by examining the social and sexual networks of men who have sex with men in Columbus.
“Since 2011, syphilis has been increasing dramatically in the U.S. and in cities like Columbus,” said Dr. Miller. “This research will hopefully help us understand why. Syphilis isn’t a trivial infection. We’ve seen an outbreak of ocular syphilis nationwide, a complication that can cause blindness when treatment is delayed.”
The researchers will partner with Columbus Public Health and Equitas Health on the project. These partnerships are essential to the work, according to Dr. Miller.
“The collaboration with Columbus Public Health is critical,” said Miller. “It’s also a way for us to further develop an academic-government effort to examine this issue.”
“Equitas Health’s role is also important. They will be a site for community engagement and recruitment of individuals for the study. We will contract with them for those services and staff needed for the research, and the project will build a sustainable research partnership between OSU and Equitas Health,” said Dr. Miller.
Columbus was one of three cities, along with Baltimore and Chicago, chosen for the three-year study.Ohio State